Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
Clinical trial NCT00506519 · TERMINATED
Trial details
- NCT number
- NCT00506519
- Sponsor
- LEO Pharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.